Rwanda Legal THCa Rick Simpson Oil: OilWell Cannabis Houston Delivers 16,590mg 7-Cannabinoid RSO Sublingual Oil with 553mg/mL & 1,500mg Patient-Controlled THCa—Baylor-Trained Founder, Bentley’s 10-Year Miracle, Lab-Tested, 7-Time ABC13-Featured & Hemp-Derived Farm Bill-Compliant International Shipping

OilWell Cannabis yubaka: Rick Simpson Oil (RSO) ku Rwanda — Iteganywa ruzuye

Twubatse ibintu hano kuri OilWell Cannabis twebwe dukunda ko bifite agaciro ku bantu bakeneye cyane — nibasangayo ari mu Houston, Texas, cyangwa i buryo buteho bw’isi mu Rwanda. Iteganywa iri ntabwo ricye gusa kugurisha ibicuruzwa. Ni ukuvuga ukuri, kugabura ikoranabuhanga, no kuguha ubushobozi bwo kwisanga ibyo byuririraza umubiri wawe, ubuzima bwawe, no muryango wawe. Turi kompanyi izwi ku miterere ya Houston ifite umutima wo kubaho mu bice by’umupaka, ukwizerwa kwa venereri wubuzima, no inzoka yitwa Bentley yatudahiriye ko ibinyabuzima bya kannabis bikora ibitagira amafaranga yakwiriye. Twagaragariwe na ABC13, twahinga kannabis ku kamera, kandi twahatse amasosiyeti yacu ku bice bitandatu by’isi. Ubu, turimo tugeze ku Rwanda — ku bakinnye kanseri mu Kigali, ku bafite umutwe w’umubiri mu Butare, ku basirikare bafite PTSD mu Gisenyi, ku buri wese ushakisha ibisubizo by’ukuri kuri Rick Simpson Oil.

Kumenya Rick Simpson Oil: Inkuru y’ibyavuye byera ishingiye kuri Rwanda

Rick Simpson ni nde?

Rick Simpson yavukiye mu 1949 mu Amherst, Nova Scotia, Canada. Ntiyari umuganga, umushakashatsi, cyangwa umusayensi. Yari umunyamikorere mu makineri n’umukozi w’ibikorwaremezo — umunyamwuga w’ibikorwa by’ikoranabuhanga kandi ubuzima bwe bwahindutse iyo medisini y’ukwezi kwaguye. Mu 1997, ubwo yakoraga ku bitaro mu Moncton, Simpson yaguye avuye kuri scaffolding akomeretse umutwe. Ibyo byateraga: tinnitus idakira, amakomari, simptomes zo guhungabanya umutwe zitari zishira. Amafaranga yakubwiye umuganga we cyangwa yakoresheje byarabaye byarahumanye. Uko yabonye ko kannabis yamuhindukiriye byiremewe kurusha ibindi, umuganga we yasuye gukiganirira. Iyo kwanga — uwo mwanya nibitabazwa n’ubuzima bw’umuryango — ni ikintu abantu mu Rwanda bamenya neza. Nibasangaho mu bice byo mu mashyamba haranira abaganga b’ikigo, cyangwa mu Kigali buri gukorana na gihe kirekire, ubuzima bwo kurengerwa n’ubuzima bw’umuryango ni burebure.

Ucuramye kwa Simpson kwiyongera noneho yabonnye ubushakashatsi bw’ikigo cya NIH bwafashwe mu 1974 ku Mikwe y’Irembo mu Virginia bwaratumye THC ikurira ukurura kwa vuba kwa kimera mu nyamaswa. Ubwo bushakashatsi — bwari bwatekereza kugaragaza ububi — bwagira umutima we, nubwo ubushishozi bwayo butahakanye mu bushakashatsi bw’ikigo ku bantu. Ighe kibereye cyose cyabaye mu 2003 ubwo, hasi ya rubarwe, amatanda atatu ku rugaro rw’iganze yakiriwe nk’ikimuranga. Simpson atewe na kimuranga gikorerwa, yahinduye amavuta y’ikigegesishe ku kibyimba, yabikijije n’impeke, arashikiriza ko amatanda yaguye mu munsi enye. Nta kugaragaza ku bitaro bitanzwe. Nta kemeza cy’avuze. Ariko iyo myize y’umuntu ku giti cye yarateye inkuru y’ibyavuye ya Rick Simpson Oil, izina rishyirwaho kuva Nova Scotia kugeza Nairobi, kuva Vancouver kugeza Kigali.

Ibishingiro by’ingenzi: Tugaragaza inkuru ya Simpson nk’eby’umuntu ku giti cye, si nk’ibimenyetso bwa muganga. Ni iby’ingenzi mu mateka nk’ikintu cyateye iterambere ry’isi yose, ariko ntikivurwa nk’ibimenyetso bwo mu kigo. Ku banyarwanda bashaka ibisubizo by’inyongerwaho nyumara guhera ku bibazo by’aho baba, iyo nkuru irimo — ariko isuzuma ry’ibimenyetso bikurikira ari ibyapfubura icyizere n’ubuhangane.

Iterambere: Uko RSO yaturutse isi yose

Nyuma ya 2003, Simpson yiyemereye gukora no kugabura amavuta ku buntu. Yahufitiye abantu bafite kanseri, umutwe w’umubiri, diyabete, indwara z’imyitozo, glaucoma, arthritis, uw’ubwoba, insomni, n’ibindi — byose ku buntu. Iki kimwe cye cya 2005, Run From The Cure, cyasakaza inkuru ye ku isi yose, kibanga iby’ingenzi mu baturage b’ikigo. Ku banyarwanda benshi bahura kuri RSO ku buryo bwa internet cyangwa ku miryango yo mu mahanga, iyi firime yari iyambere.

Ariko inkangurambaga ya Simpson yatuyemo amakimbirane n’ubutegetsi. Polisi y’u Rwanda (RCMP) yamushutse inzu ye mu 2005 na 2009. Yavunzweho ibihano byo kurima, kugira, no kugurisha. Yakomeza ahurira n’ingufu, yasimbutse Canada agana mu Burayi, akomeje inkangurambaga ye mu Croatia no mu Netherlands. Mu 2012, yashyize kure Phoenix Tears: The Rick Simpson Story akaguma na phoenixtears.ca nk’urwego rye .

Mu gihe cyose cy’imirimo ye, Simpson yaragiye agumya ko RSO ishobora gukiza kanseri n’indwara nyinshi, kandi ko ibigo by’amafaranga, ubutegetsi, n’ibigo by’ubuzima byabambaga ubu bushakashatsi. Yabyibaga nk’urugamba ruri ku bantu. Iyo ndorerwamo — yakomerekejwe n’ubujiji no kubura umutekano — isanga benshi muri rusangi rusange ry’abiyambariye kannabis, harimo n’abaturage mu Rwanda bababye ibigo bitabereye.

Ibishingiro by’ingenzi: Indorerwamo ya Simpson yo kubesha ibigo ikurikira uko ryatekereza mu nkangurambaga ya kannabis ya mbere. Ni ingenzi kumenya icyo RSO aricye ariko bitari kuwemerera. Uburyo bwacu kuri OilWell bunanirana: turwanya ibinyoma n’ibimenyetso, atari n’ibindi binyoma.

Ingingo y’ikinyabuzima cya RSO: Gramu 60 mu minsi 90

Igitekerezo cya Simpson cy’ingenzi cyari icy’uko: kurya gramu 60 za vuba zavuzweho mu minsi 90. Iyi niyo ingingo yakiriwe nk’imiti ya kanseri, nubwo yikoreshaga ku ndwara nyinshi. Hano ni iby’ingenzi:

Igikorwa

Kurya gramu 60 (kureba mL 60) z’amavuta yavuzweho mu minsi 90.

Gahunda yo Kurya

• Indwi ya 1: Igice cya umugori w’umuceri — gramu 10-15 z’amavuta — gatatu ku munsi. Yose: gramu 30-45 ku munsi.
• Indwi 2-5: Kongera ibyo wurya buri minsi ine. Ku indwi 5, kugeza gramu 1 (1,000 mg) ku munsi, ibyiciro bitatu.
• Indwi 5-12: Komeza gramu 1 ku munsi (gramu 333 ku giti) kugeza 60 zose zimaze.

Uburyo Bwokoreshwa

• Ku munwa (by’ingenzi): Ongeraho munwa cyangwa womeke kugira ngo yinjire mu ubuzima bw’umubiri.
• Ku ntoki (by’inyongerwaho): Ongeraho ku kibyimba kiri ku ntoki n’impeke, usimbure buri minsi 3-4.
• Kunywa (siby’ingenzi): Simpson yemereraho kunywa kugira ngo buhe abantu umuti wo kugaragara ariko yatinze ko kurya ku munwa by’ingenzi kugira ngo umuti wihariye ugire ingaruka.

Ubushobozi no Kwikunda

• Simpson yashimangira ko abantu bagira ubushobozi bwo kurya THC mu minsi 3-4.
• Yabashishikarije gukoresha iyo miteguro mu gitondo kugira ngo baryame babashe kureba ubusa.
• Yabambikiye kudahagarika imodoka cyangwa imashini mu gihe barya.

Guhita Intego Nyuma yo Kuvanamo

Nyuma yo gusoza 60 gramu, Simpson yabashishikarije gramu 1-2 ku kwezi ibihe byose kugira ngo ubuzima bwiza bukomeze bureke kanseri.

Ingingo yo Kurya

Simpson yabashishikarije kugabanya sucrose, kwirinda ibiryo byakozwe, no kuvura indyo — amakuru y’ubuzima rusange, sibyo utekerezemo.

Ibishingiro by’ingenzi ku banyarwanda

Iyi ingingo yakozwe na umuntu ku giti cye hasi ya rubarwe, si ku busuzumwe bw’ikigo. Iby’ingenzi byakwirikira byakwiriye ku bari mu Rwanda barimo kurwanya iyo ingingo:

• Nta busuzumwe bw’ikigo bufite. Nta bushakashatsi bwakozwe mu kigo, nta sudy y’abantu, cyangwa nta gahunda ndangabitsi yagiye yandikwa ijyana n’iyo ingingo.
• Igihano kitarazwa. Amafaranga buri gipimo byari bitandukanye hasi ya rubarwe ku muceri w’igitangaa, uko wahingiye, no uburyo wavuyemo.
• THC yirenye cyane. Ku gipimo kinini (gramu 1 ku munsi ya vuba 60-90% THC), abantu barya mg 600-900 za delta-9 THC ku munsi — irenze byine ibikenewe mu bushakashatsi. Kugira ngo wibuke, dronabinol yemejwe na FDA ifatirwa mg 2.5-20 ku munsi.
• Ibibazo by’ukuri mu gipimo kiri ibi. Ubusa bukaze, kugabanya ubushobozi, ubwoba, umutima ukabyuka, tachycardia, hypotension, no gukoresha kannabis byose biravugwa mu gipimo kinini [1][13][14][15].
• Umutwe ukomeye wa onkoloji. Abakiri kanseri bafite umutwe ukomeye. Gukoresha amavuta atagenga nka miti ijyana — hatangira gato cyangwa guhita intego — bituma habaho ubusa burenze vuba.

Ku bakiri kanseri mu Rwanda: Tubashishikarira kubwizana n’ibigo by’onkoloji muri aka gace nka Rwanda Cancer Centre kuri Rwanda Military Hospital mu Kigali, cyangwa Butaro Cancer Centre mu karere ka Burera, mbere yo guhitamo umuti. Amakuru ku RSO agomba kuzana umuti, atari guhita.

Ibyarigen RSO by’umwihariko

RSO ntari igenerwa na gipimo, ari by’uburyo. Hano ni ibyo Simpson yakoraga:

Ibyavuyemo

Umwihariko wa kannabis wigega THC, w’indika. Nta gipimo — byatandukanye hasi ya rubarwe.

Impeke yo Kuvuyemo

Naphtha (peteroli y’imiteri) cyangwa alikololi 99%. Nta kibyari bikoreshwa mu biryo. Naphtha ishobora kugira benzene, toluene, n’ibindi binyabuzima bibyitirira. Ugushira impeke ityo bigatuma kigira ibitarimbye.

Uburyo Bwokuvuyemo

1. Shyira kannabis ifashe mu baki.
2. Tegereza impeke ugaturabature amasegonda.
3. Kanda mu musarani.
4. Ongera impeke nshya.
5. Tegura impeke mu rice cooker ku mashyuza.
6. Tegura amavuta ameze nk’amata, amavuta y’amavuta, akoranye na syringes.

Igihumbe

Amavuta amenetereza, atukye nk’amata, amenetereza, ifite ucuha nk’amavuta, ifite urunyerezo rw’ikigegesishe, ifite urunyerezo rw’impeke.

Ibisobanuro by’Ibinyabuzima

• Byose byahindutse (THCa yose yahindutse delta-9 THC).
• THC y’ingenzi (60-90% byagenewe), hamwe n’ibinyabuzima bito hasi yo rubarwe.
• Nta kugenzura by’ikigo. Nta COA.

Igihumbe bya Terupene

Ntacyari kirimo cyane cyangwa byose. Impeke n’umuriro ukaze byaninze iterupene.

Gipimo n’Ubusuzumwe

Ntakintu. Amafaranga buri gipimo byari bitandukanye. Nta kugenzura by’ibyitirira.

Ingaruka za Impeke

Iyi ni inenge y’umutekano. Ubwoko bwa RSO bukozwe nk’uko bikorwa na Simpson bukoresha naphtha cyangwa alikololi itari y’ibidukikije. Ugushira impeke ityo ntigukikira kigihumbe — bigatuma habaho ibishishikara by’impeke muby’ukuri.

Iyo nyabugeni ikurura naphtha mu banyarwanda: Ubwo iyo gipimo yakozwe nk’uko bikorwa na Simpson, igihumbe cyakoraga naphtha. Igihe umuntu yabishyira kuri kibyimba, naphtha yari mu mubiri. Iyo nyabugeni ikurura ibyitirira byumvikana — bigatuma abantu bafite umutekano muby’ukuri.

Gahunda y’Ibyakagombye kandi Iyafashwe

Mu rwego rwo kugira umutekano, igihumbe cy’ubu cyakoresha etanoli cyangwa CO₂ — ibyo bikikira impeke ityo. Ibi ni by’ingenzi cyane ku mubiri w’umuntu.

Igihumbe cyacu sicy’ikoreshwa rwa RSO nk’uko cyabereye. Ni gipimo cy’umuhondo wa cannabinoids zose, zikoreshwa mu gikorwa cya RSO. Nta naphtha. Nta alikololi. Nta butane. Etiro etari y’ibidukikije. Nta impeke.

Ugushaka: COAs buri gipimo — buri muri buri wese. Kugenzura ibinyabuzima (HPLC/UHPLC, ±2% umumaro). Kugenzura ibinyabuzima by’imicungire (ICP-MS: arseniki, cadmium, plumu, mercury). Kugenzura ibinyabuzima by’iminyorogoto (400+). Kugenzura impeke (headspace GC). Kugenzura ibinyabuzima by’ubwumvikane (E. coli, Salmonella, Aspergillus).

COAs zishyikirizwa kugira ngo uzisuzume. Ku banyarwanda, tunozisanga ku kintu cy’interineti.

Ubuharizi: Ubushobozi wo Kugenzura

RSO rya mbere rwari rugenzuye — kungana. Igihumbe cyacu kiriho 1,500 mg za THCa, kugira ngo ugire uburyo bushya:

Uburyo 1: Kitajya, Nta Muriro (Kitabashisha)
THCa 1,500 mg zose ziguma zitajya. Ubushakashatsi ku THCa bwerekana ko ifasha mu gukiza ubwoba bwo gukoresha COX-2 no gufasha ubwonko muri PPARγ. Ibyiza ku munsi mu Rwanda — ushobora gukora, gutwara imodoka, gukura abana, gukora ibyo wigenza nta busa.

Uburyo 2: Byose Byarashije (Decarboxylation yo Murugo)
Shyira amavuta kuri 260°F (125°C) amasegonda 45-60 mu gisanduku cy’amaso. Ibi bihindura mg 1,500 za THCa kuba ~mg 1,315 za delta-9 THC. Hamwe na mg 90 za delta-9 THC zari ziriho, ujya ufite ~mg 1,405 za delta-9 THC — ubushobozi bwo kugaburira bukuze, bukimilike na RSO rya mbere, ku buryo bwemewe 100% kuko wowe uganira uburyo.

Ushobora gushyira muriro gusa ku gice: Tegura igice mu gisanduku cya kabiri, ushyire muriro, usibire igihumbe.

Uburyo 3: Vape, Decarboxylation Yitaho
Igihumbe cyacu cya RSO Vape Cartridge cyashyushya kuri 400-450°F, gihindura THCa kuba delta-9 THC buri mugeri. Kugaruka mu min 1-2, uhereye mu isaa 2-4. Umuti wo hafi.

Ubucukumbuzi: Mg 1 ya THCa = mg 0.877 ya delta-9 THC nyuma yo decarboxylation.

Iyi gahunda yashyizemo ubushobozi bwo kugenzura ubushobozi — bifitanye isano na gahunda ya Simpson ko umurwaye akwiye kugenzura umuti we, ariko bikibagura mu bucukumbuzi butari mu magambo.

Ibiro by’Ibigenga: Ibyarigenze n’Ibyubu

Rick Simpson yakoreye mbere y’itegeko, mbere yo kugenzura. Ibyagenze bye byari iby’umuntu ku giti cye, ubwoko butazwi, ibyemezo bitazwi. Ibi byari uburere.

Iteganywa riri rishyira ku bikoresho by’urwego: ibimenyetso by’umuntu mu kigo by’ingenzi, hanyuma amasuzumabumenyi, hanyuma amakuru y’ibigo, hanyuma amashusho y’ibigo [1]-[29]. Buri kintu cyose cyavugwa ku gipimo twacyita ku nyandiko zivugwa na benshi zimenyetse ubusa.

Iteganywa riri ari ryo teganywa ryo musingi.

KUBAHO OILWELL CANNABIS: Inkuru yacu, Intego yacu

Kuva Kumupaka kugeza ku Venereri w’Ubwami

OilWell Cannabis yashyizweho na Colin Valencia mu Houston, Texas. Colin yavukiye mu McAllen, Texas — hafi na Reynosa, Tamaulipas, Mexico, mu bice by’umupaka. Ni bumwe mu bice by’umupaka bitabereye ubutunzi n’ibibazo by’umutekano. McAllen ifite ubuzima bwiza ariko ubuzima bwiza ntiburenga ubwonko n’ubuzima. Reynosa ni inzu y’ubwubatsi ifite umutekano w’iterabwoba. Colin yari amaze kubona ibi — gutwara ibicuruzwa ku mupaka, kubona iterabwoba, kubanza abafite ubuzima bwiza bapfuye cyangwa bafungiwe. Ku myaka 16, yari agomba kuva mu rugo iteka.

Nubwo hari ibibazo, Colin ntiyagwiriye kubikoresha. Yatoranije kannabis, yigeze uko ishyanga irimo mu isi y’itegeko, yinjira mu bikorwa remezo. Yaba umukozi wubwoko mu bucukumbuzi bw’imikoreshereze, akora ibikorwa remezo kuri Baylor College of Medicine mu Texas Medical Center — ikigo cy’ubuzima n’ubushishozi. Iyo kwihuza ubumenyi bukomeye n’ukwizerwa kwa venereri ari bwo bwumvise neza OilWell.

Ku banyarwanda, iyo nkuru n’ingenzi kuko iturutse mu bibazo, mu bice bitabereye umutekano. Iyo ubutungane bushyigikira kwizerwa n’uburenganira ku bantu nk’abo muri mwe.

Bentley: Inzoka yateye byose

Inkuru y’ishyirwa ryacu ry’ubutunzi yitwa Bentley. Bentley yari ikintu gikomeye — yari mu muryango. Uba venereri bamwemereye ubutumwa butakunda (euthanasia), Colin yabyanze. Bentley yari afashe mu maguru ye abiri. Amafaranga yo kubabaza byazunguraga iby’ubuzima ye. Intego yari ukwihushya cyangwa ubutabazi bukemutse.

Ariko kwanga kutiyikoresha byari intego. Mu kuvaga, Colin yabonye CBD ku busubiza hamwe na Jessica. Iyo busubiza bwabaye inkingi y’iteganywa.

Colin yigeze gukora CBD golden paste — umuti w’ibinyabuzima by’ikigegesishe kuri zina. Ntabwo ari umuti, ariko icyizere. Icyizere cyamukoreye icyashidikanywaga: Bentley yiyongeraho, yagiye, yamuje umupira. Ukuhereyeho gutwara umupira. Inzoka ntishobora kubona placebo. Iyi yari imiti ya kannabis ikora ibitagira amafaranga yakwiriye.

Bentley yagumyeho imyaka 10, apfa mu buryo bw’umwihariko ku myaka 20. Muri ibyo myaka, Colin yakozeko formulas ku ndwara zose:

• Uwonko uhunganye → CBG n’ubworozi bw’ubuzima, THCa yo gukinga ubworozi
• Iwonjora → CBC mu gufasha ubwonko
• Glaucoma → THC yo gukiza ubuhumane
• Arthritis → Kugabanya ubwoba butandukanye

Icy’umwe nticyongeraho. Ibintu bya Bentley byari bitandukanye. CBD itagira umuti wo kwonona ubwonko, iwonjora, glaucoma, n’arthritis. Ibinyabuzima bito byari by’ingenzi. Ubwizerwa bw’ibigega by’ubuzima bwari ingenzi — ubuzima bwa Bentley bwategereje umuti w’ukuri, atari ubushishozi.

Inkuru ya Bentley yari iyo ngingo ya Colin muri kannabis itazwi. Yarateye intego yo gukora ibisubizo by’ukuri by’umuhindi — ku zina n’abantu. Bentley yateje kwizerwa, ubushya, no kwishimira.

Intambara ya Colin: PTSD, Ubujiji, n’Amagi ya Peace

Colin yazi neza uburwayi bwo gukoresha amafaranga. Yafashwe na PTSD n’ubujiji. Ubwo yabyanze gukoresha Xanax, yarabyanze — byanze bikomeye — akoresha ubumenyi bwe bwa kannabis bwahumuye Bentley.

Formula ya Peace Gummies yakozwe mu minsi yo kuganirana n’ibijiji. Ihari na muri vape kugira ngo uhindure ibibazo byo hafi — Colin akoresha ko gucunga PTSD yinshi n’insomni. Ibi ntiby’umugambi. Yabaye mu bihe bya RSO.

Ku banyarwanda bahuriye n’ibihe by’ibibazo — byaba kuva ku bwoko bw’udusetsi, ibibazo by’umutekano, cyangwa ibihe by’umubyeyi — iyo nkuru y’umuntu ku giti cye ifata gurtya.

Abaganga Bakoresha Formulas Zacu

Mu gihe cy’amahoro, imiti Colin yabonye kuri Bentley yaba iby’ingenzi. Yaba yakozeko formulas abaganga bakoresha ku ndwara z’amagara, PTSD, ubujiji n’insomni. Icy’ingenzi cy’iwe ni ugufasha kubona kannabis y’ukuri y’ukuri.

ABC13 Houston: Imikino 7, Umuntu Umwe

Kuva mu Nzeri 2019 kugeza mu Mata 2023, ABC13 Houston (KTRK) — ikigo cy’itangazamakuru cy’ABC — cyagaragaje Colin na OilWell Cannabis mu mikino ndangabitsi 7. Abacurabahinga 5 bamushakiye mu myaka 4. Nta kompanyi yindi ya kannabis mu Houston ifite uwo musaruro.

Imikino:

1. Nzeri 2019 — CBD izungura bizimiza; amagambo ya Colin.
2. Werurwe 2021 — Gukuramo amasezerano; amagambo ya Colin.
3. Gicurasi 2021 — Delta-8 THC; ubwerekeye Colin.
4. Nyakanga 2021 — COVID vaccine; 1,000 caviar pre-rolls.
5. Ugushyingo 2021 — Delta-8; amakuru ya Colin.
6. Ugushyingo 2022 — Biden; Colin yabwiye amateka ye.
7. Mata 2023 — Amategeko ya Texas; amagambo ya Colin.

Iyo mateka y’ikigo cy’itangazamakuru ifite ubusobanuro — siyo kwiyambarira. Ku banyarwanda, iyo kwakira kwemerwa n’ikigo kikomeye gikora umutekano.

Ibikorwa by’Ubu: Ubuzi, Ububiko

Ubu, OilWell Cannabis ikora mu Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Kuva mu 2019, twagize inyungu zimwe ku myaka, tubafite Google rating ya 5.0, kandi tubifite Texas DSHS license. Ibicuruzwa byose, formulas, n’imikorere byose bikorwa mu Houston — atari mu bikorwa binini, ariko bikorwa n’umugambi.

Umutekano wacu ni w’umwihariko: gukora ibicuruzwa n’umugambi, kugabura ukuri, kandi kutinye kannabis izwi.

FOUR PILLARS FOR RWANDA: Intego Zacu

1. Uburenganira Aho Gutegurwa

Nta cyemezo cy’umuganga gikenewe. Umunsi w’imyaka 21+ ushobora kugura. Turahatse mu bice byose by’Amerika no mu mahanga. Ku Rwanda, ibi bivuga iteganywa. Ntabwo ukeneye kugira indwara yemejwe cyangwa uruhushya rw’umuganga. Ukeneye umuntu w’imyaka 21+ ukora gahunda yuzuye.

2. Umurwaye Uganzura Ubushobozi

THCa igurishwa mu buryo bwayo bw’iby’umwihariko. Wowe utegura: kuyikoresha kitajya kugira ngo ufungure mu mpari, cyangwa decarboxylate kugira ngo uhindure ubushobozi. Ibi bifitanye isano na gahunda ya Simpson umurwaye agenzura umuti we, ariko bikibagura mu bicukumbuzi.

3. Formulas Zishyikirizwa

Tugaragaza formulas zacu zose — ibinyabuzima buri kinwe, buri gramu, buri percentage. Niba utajya $129.99 y’amavuta yo ku munwa cyangwa $49.99 ya vape, ushobora kugura ibinyabuzima ukore ubikozwe ubwe. Ibi birangiza gahunda ya Simpson yo kugabura ku buntu.

Formula ya Bentley golden paste twashyize ahagaragara imyaka mbere RSO irimo isobanura ko iki kintu ni cy’ingenzi, sibyo kwiyambarira. Ku banyarwanda bakora ubikorera, ibi n’icyizere: formula yakemuye ushobora guhindura n’iby’ahantu (turmeric, amavuta y’ikigegesishe, black pepper) niba ushobora kubona CBD isolate.

4. Ihuzwa n’Ibigenga, Si Gushimika

Simpson yakoreye atagira amakuru. Dufite amakuru ayo dukoresha kugira ngo twebure icy’ukuri n’icy’umwihariko. Igice cy’GENERAL KNOWLEDGE kikurikira gihuza ubu bushakashatsi ku gipimo twakozwe.

Iteganywa riri risobanura byose.

KURENGA AMAZINA Y’UMURIMO: Iby’ubusa

Icyemezo cya 2018 Farm Bill: Ibiguye Rwanda

Itegeko rya 2018 Farm Bill ryemeye hemp n’ibicuruzwa byayo byo mu buryo butajyanye 0.3% delta-9 THC mu gipimo kare mu ntebe y’igihugu mu Amerika. Iyi niyo teganywa ry’igihumbe cyacu.

Igihumbe cyacu cya RSO Sublingual Oil gifite mg 90 gusa za delta-9 THC mu bote 30 mL — mg 3 ku mL — irenze 0.3% threshold. Ibinyabuzima byose ni by’ikigegesishe. Igihumbe ni cyo mu rwego rw’igihugu.

Ubusobanuro bwa THCa: THCa ni icy’imbere kirenze cy’icy’umwihariko. Si delta-9 THC aho igurishwa, bivuye mu Farm Bill.

Umukiriya Uganzura: Ubucukumbuzi uganzura

Ushobora decarboxylate THCa kugira delta-9 THC mu rugo ushyira amavuta kuri 260°F (125°C) amasegonda 45-60 mu gisanduku. Ibi bihindura mg 1,500 za THCa kuba ~mg 1,315 za delta-9 THC. Hamwe na mg 90, ujya ufite ~mg 1,405 — ubushobozi bukudari RSO rya mbere, 100% bwemewe kuko wowe uganzura.

Ushobora gushyira muriro gusa ku gice: Gura igice mu gisanduku cya kabiri, ushyire muriro, usibire igihumbe.

Icyemezo kubwa Umukiriya w’u Rwanda

THCa ihinduka delta-9 THC iyo yishyuwe. Umukiriya ni we witeguye no kureba amategeko y’u Rwanda. OilWell yohereza inyandiko zose, COA, n’amatangazo. Abakiriya b’ibigize by’isi bemerera byose. Tubashishikarira kubuza Rwanda Revenue Authority (RRA) n’Ubutegesti bw’Ubuzima mbere yo gushaka.

Nubwo amategeko y’u Rwanda arimo umutekano, ibicuruzwa by’ikigegesishe byo mu buryo butajyanye 0.3% delta-9 THC aho igurishwa bifite ubusobanuro bukomeye. Inyandiko zacu ziratanga delta-9 THC, zirakomeye ku mupaka. Ariko ntitubasha kugira ngo tubishe amategeko y’u Rwanda. Gura nyuma yo kwemerera ubusa.

FORMULAS ZISHYIKIRIZWA: Impamvu tuba zishyikiriza

Tubarasa formulas zacu zose — ibinyabuzima buri kinwe. Amatafari aburikira ni ibipimo by’igihumbe n’imikorere y’ubikora.

Formula ya RSO Sublingual Oil

Ibinyabuzima	Igipimo
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Ibinyabuzima byose	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Uburyo: Bote 30 mL
• Gutanga: Organic MCT oil
• Buri mL: 553 mg ibinyabuzima
• Kugaruka: Min 15-45 (ku munwa)
• Iherezo: Saa 1-2
• Igihe: Saa 4-6
• Bioavailability: 13-19%
• Gipimo cy’umusegonda: 40-60 ku bote
• Igiciro: $129.99

Ku banyarwanda bakoresha: Niba ushobora kubona distillates, ushobora gukora formula. MCT oil iri mu Rwanda. Iterupene idategereje kubibona, ariko ibipimo by’ibinyabuzima bishyikirizwa.

Formula ya RSO Vape Cartridge

Ibinyabuzima	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Uburyo: Cartridge 1 gram
• 510-thread: Ubundi buryo bukoreshwa na bose
• Kugaruka: Min 1-2 (ndangagutangariza)
• Iherezo: Min 10-15
• Igihe: Saa 2-4
• Bioavailability: 10-35%
• Igiciro: $49.99

Formula ya vape yahindura THCa ku gipimo 400-450°F.

KURENGA AMAZINA Y’UMURIMO: Umutekano

Igihumbe cyacu sicy’ikoreshwa rya RSO nk’uko cyabereye. Ni gipimo cy’ibinyabuzima byose byavumbuwe mu giharuro. Nta naphtha. Nta alikololi. Nta butane.

Gutanga: Organic MCT oil

Ubusuzumwe: Buri gipimo bigenzurwa:

• Ibinyabuzima (HPLC/UHPLC, ±2%)
• Ibinyabuzima by’imicungire (ICP-MS)
• Ibinyabuzima by’iminyorogoto (400+)
• Impeke (headspace GC)
• Ibinyabuzima by’ubwumvikane (E. coli, Salmonella, Aspergillus)

COAs zishyikirizwa ku kintu cy’interineti. Ku banyarwanda, tuzosanga na tracking number.

PORTFOLIO ZACU ZOSE

Kurenga RSO, turimo gukora:

• Asshole Peach — Igihumbe cyacu cyishimye cyane. Peach gummy rings zifite 268 mg ibinyabuzima (28 mg Delta-9, 50 mg Delta-8, 20 mg Delta-10, 20 mg THCo, 100 mg CBD, 50 mg CBG). Yakunzwe cyane n’abasrikare ku PTSD.
• Peace Gummies — Yakozwe ku bwa Colin. Peach 320 mg ibinyabuzima (30 mg CBN, 15 mg Delta-9, 25 mg Delta-8, 100 mg CBD, 150 mg CBG). Hari na muri vape.
• Custom Creations — Formulas ziteganywa ku giti cyawe.

UBUFATANYE BW’IBICURUZWA: Bubiki ku Rwanda?

RSO Sublingual Oil ($129.99)

Kugira ngo umuti ukomeze. Koreshea kitajya mu mpari; decarbya mu nsozi.

RSO Vape Cartridge ($49.99)

Kugira ngo umuti ugaruke vuba. Ibyiza ku kibazo cy’umutwe, ubwoba, cyangwa gusesa. 510-thread batteries zirishoboka mu Kigali.

Igihe yo Kugira

Use Case	Bubiki by’ingenzi	Impamvu
Umuti wo vuba (umutwe, gusesa, ubwoba)	Vape	1-2 min kugaruka
Umuti ukomeze (umutwe, umurimo)	Sublingual	Saa 4-6
Bioavailability y’ingenzi	Sublingual	13-19%
Kugenda/kwanga kutabona	Vape	Gito, nta gupima
Gupima neza	Sublingual	Dropper
Munsi mu mpari	Sublingual (raw)	THCa itaba
Munsi mu nsozi	Sublingual (decarbed) cyangwa Vape	THC + CBN

IGIHE CYO KUBAHO: Impamvu zikwiriye

Icyemezo: Izi mpamvu zikozwe ku bushakashatsi bw’ibinyabuzima. SIBYO amafaranga, SIBYO FDA yemeje, SIBYO ibyemezo by’umuganga. Ibicuruzwa byacu ntibisuzumwe na FDA kandi ntibishobora kubuza, kuvura, cyangwa kubuza indwara. Bisa n’ugutanga umuganga ushoboye mbere yo kugira.

Gusesa & Gutanga Igihe

• Mbere yo kuvanamo: 0.5-1.0 mL sublingual ~saa 1
• Gusesa vuba: 2-3 vape puffs
• Nyuma yo kuvanamo: 0.5 mL sublingual buri saa 6
• Umurimo: 1.0-2.0 mL sublingual

Ubusobanuro: Delta-8 antiemetic [9], Delta-9 gusesa [1][13], CBD anti-anxiety [3]

Umutwe (Fibromyalgia, Arthritis, Neuropathy)

• Munsi mu mpari: 0.3-0.5 mL raw sublingual
• Munsi mu nsozi: 0.5-1.0 mL decarbed sublingual
• Vuba: Vake

Ubusobanuro: CBD umutwe [4], Delta-9 umutwe [13], beta-caryophyllene CB2 [24], THCa COX-2 [12]

Umurimo

• Mbere yo kurara: 1.0-2.0 mL sublingual
• Ku 2.0 mL: 50 mg CBN
• Ku 1.0 mL: 25 mg CBN

Ubusobanuro: CBN umurimo [16][17]

Ubwoba

• Munsi mu mpari: 0.3 mL raw sublingual
• Munsi mu nsozi: 1.0 mL sublingual

Ubusobanuro: CBD ubwoba [3], CBG [7][8], limonene [20]

Uburezi Rusange: Tangira hafi, komeza buhoro. Tanga 0.25-0.5 mL sublingual ukurikize ingaruka mu min 2-3 mbere yo kongera. Ibi bitandukanye ku buri wese.

KOHESHA: Kugura OilWell RSO mu Rwanda

Kohereza mu munsi ku mwe mu Houston

Turimo guukora gusa kohereza ku munsi mu Houston, ku venereri w’ubuzima (the world’s largest medical complex, 10M+ patient visits annually). Iyi gahunda yo kubohoka buri murwaye n’ingenzi turi mu Rwanda.

Kohereza mu Bice Byose

Kubanyarwanda:

• Turahatse mu Rwanda via USPS Priority Mail International (imin 6-10) cyangwa FedEx/UPS (imin 3-5).
• Ingingo zose ziriho: COAs, amatangazo, n’inyandiko z’imipaka ziratanga delta-9 THC (<0.3%).
• Impapuro ntiziramye.
• Tracking number iriho.
• Impapuro z’umutekano mu bihe bitandukanye (Rwanda 25-28°C).
• Ubusa: Umukiriya wa Rwanda ni we wita ku mategeko. Ntitubonera ko imipaka y’u Rwanda izakira ibicuruzwa. Tubashishikarira kubuza RRA n’Ubutegesti bw’Ubuzima.
• Inama: Gura vape cartridge kugira ngo ugire ibiro bike.

PANDEM1C SEO Technology

Ubucukumbuzi bwacu bw’14 million kugeza ku bice 300+ bw’ubucukumbuzi bwo mu buryo butandukanye bureba isi yose. Uwo muntu mu Kigali asubiza “RSO for cancer Rwanda” cyangwa “buy RSO Rwanda” — itegeko ryacu rikaza.

UMUHANGA: Uburyo Formulas zacu Zihura n’Ibigenga

Buri cannabinoid muri formula (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) ifite ubusobanuro bw’ibyo BIGENERAL KNOWLEDGE. Buri terupene (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) ifite ubusobanuro.

Formulas zacu zifitanye isano n’ubushakashatsi ku gipimo. Ntitwiyongera muri iyi mpamvu.

GENERAL KNOWLEDGE: Ubucukumbuzi ku Binyabuzima Buri Kinwe

Uburyo Bw’Ubushakashatsi

Dutegura amashusho:

1. Ubushakashatsi bw’umuntu mu kigo
2. Amasuzumabumenyi
3. Amakuru ya NIH
4. Amashusho yo muri kigo

Ibi bikomeye kuko amakuru arimo. CBD na delta-9 THC bifite ubushakashatsi bw’umuntu; ibindi bifite amashusho.

Amakuru ya NIH

• NCCIH: Ubushakashatsi bw’ingenzi buvuga ku zina, gusesa, no gutanga. Ibintu byinshi bifite ibisubizo [1].
• FDA: Ntiyemeye ikinwe cya kabuze. Ibyo yemeje ni Epidiolex (CBD) n’imitations ya THC (gusesa) [1].
• Umutekano: Ubusa, ibiza, gukoresha zuina, kubuza, kwigomeza [1].

CANNABINOID PROFILES

CBD

• Ubusobanuro: Epidiolex ku zina [1][2].
• Ubwoba: 2024 meta-analysis [3].
• Umutwe: 2024 review [4].
• Umurimo: 2023 review [5].
• Umutekano: 2023 meta-analysis [6].

CBG

• Ubusobanuro: Review, preclinical [7][8].
• Ubutungane: Precursor, CB receptors [7].
• Umutekano: Commercial CBG [7].

Delta-8 THC

• Ubusobanuro: Review [9]-[11].
• Ubutungane: Partial CB1 [9].
• Ubuzima: 2023 review [10].
• Ubukorwa: Stability [11].

THCa

• Ubusobanuro: Review [12].
• Ubutungane: Acidic precursor [12].
• Umutekano: Decarboxylation [12].

Delta-9 THC

• Ubusobanuro: Review [1][13]-[15].
• Umutekano: NCCIH [1].
• Umutwe: 2022 review [13].
• Pharmacokinetics: 2022 [14].
• Ubuzima: 2025 review [15].

CBN

• Ubusobanuro: Review [12][16][17].
• Umutekano: Sleep claims [16][17].

CBC

• Ubusobanuro: Review [18][19].
• Ubutungane: Distinct PK/PD [18].
• Umutekano: OTC products [18].

TERUPENE PROFILES

Iterupene bifite amashusho muri kigo, ariko amakuru ku bantu arakennye.

Limonene

• Ubusobanuro: Review [20]-[22].
• Umutekano: Allergen [22].

Myrcene

• Ubusobanuro: Review [20][23].

Caryophyllene

• Ubusobanuro: CB2 agonist [24].

Pinene

• Ubusobanuro: Review [20][25].

Linalool

• Ubusobanuro: Review [20][22][25][26].

Humulene

• Ubusobanuro: Review [20][27].

Terpinolene

• Ubusobanuro: Review [20][28].

IMIGERERANYA

• Ubusobanuro: CBN is proven sleep aid → Ubutungane: Evidence weak [16][17].
• Ubusobanuro: Myrcene is proven sedative → Ubutungane: Limited human proof [23].
• Ubusobanuro: THCa is nonpsychoactive → Ubutungane: Heating converts to THC [12].
• Ubusobanuro: Delta-8 is safe → Ubutungane: Psychoactive, manufacturing concerns [9]-[11].

IMPAMVU Z’AMANGAMBO

• CBD na delta-9 THC bifite ubushakashatsi bw’umuntu.
• Delta-8 THC ifite ubushobozi, butari ngombwa.
• THCa ihinduka neza.
• CBG, CBN, CBC bitajyewe neza.
• Iterupene zifite urunyerezo, ariko zitabishimikira.

IMPAMVU ZIMARA

OilWell Cannabis ni by’ingenzi. Ni kuri ku buryo bwo kohereza ibicuruzwa by’ukuri. Ntituri hano kugira ngo dukurikire amahanga; turi hano kugira ngo tubatege ibicuruzwa by’umwihariko.

Ku banyarwanda bahuriye n’ibihe byose: mufite uburenganira kwiga ukuri. Mufite uburenganira kubona amafaranga. Mufite uburenganira kugenzura umuti wanyu.

Turahatse mu Rwanda. Tugaragaza formulas zacu. Tubwira ukuri. Kandi ntituzize kannabis izwi.

Twandikire:

• Tel: +1 (832) 416-2816 (WhatsApp)
• Email: [email protected]
• Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Gura ubu. Ibyo winjiza:

• Igihumbe cyuzuye na COA
• Amabwiriza yo decarboxylation
• Formula y’ubikora
• Uburenganira bwo kubaza

Kuva Houston kugeza mu Kigali, kuva ku muhigo wa Bentley kugeza ku ntambara yawe — turi hano kugufasha.

ENGLISH

OilWell Cannabis Presents: Rick Simpson Oil (RSO) for Rwanda — The Complete Guide

We’ve built something here at OilWell Cannabis that we believe belongs in the hands of people who need it most — whether you’re in Houston, Texas, or halfway across the world in Rwanda. This guide isn’t just about selling a product. It’s about telling the truth, sharing the science, and giving you the power to decide what’s right for your body, your health, and your family. We’re a Houston-based company rooted in border-town resilience, medical-center precision, and a dog named Bentley who taught us that cannabinoids can do what pharmaceuticals sometimes can’t. We’ve been featured by ABC13, grown hemp on camera, and shipped our formulas to customers on six continents. Now, we’re reaching out to Rwanda — to cancer patients in Kigali, to chronic pain sufferers in Butare, to veterans with PTSD in Gisenyi, to anyone searching for honest answers about Rick Simpson Oil.

Understanding Rick Simpson Oil: The Origin Story That Matters to Rwanda

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, a researcher, or a scientist. He was a power engineer and maintenance worker — a tradesman whose life changed when conventional medicine failed him. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath: persistent tinnitus, dizziness, post-concussion symptoms that wouldn’t quit. The medications his doctors prescribed either didn’t help or made things worse. When he discovered cannabis provided more relief than anything else, his physician refused to discuss it. That refusal — that moment when the medical system closed the door — is something people in Rwanda understand deeply. Whether you’re in a rural district far from specialist care or in Kigali navigating long wait times, the experience of being let down by institutional medicine is universal.

Simpson’s curiosity intensified after learning about a 1974 NIH-funded study at the Medical College of Virginia that reported THC slowing tumor growth in mice. That study — meant to demonstrate harm — became his touchstone, even though its findings were never replicated in controlled human trials. The pivotal moment came in 2003 when, according to his personal testimony, three bumps on his arm were diagnosed as basal cell carcinoma. Rather than accept conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed the bumps disappeared within four days. No independent medical verification exists. No biopsy confirmation has been published. But this personal experience became the origin story of Rick Simpson Oil, a name now recognized from Nova Scotia to Nairobi, from Vancouver to Kigali.

Important context: We present Simpson’s account as personal testimony, not medical evidence. It is historically significant as the catalyst for a global movement, but it cannot be evaluated as clinical proof. For Rwandan readers seeking alternatives after exhausting local options, this story resonates — but the evidence evaluation that follows is what separates hope from hype.

The Crusade: How RSO Went Global

After 2003, Simpson committed himself to producing and distributing oil for free. He helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more — all at no charge. His 2005 documentary, Run From The Cure, broadcast his story worldwide, becoming foundational in cannabis communities. For many Rwandans discovering RSO through online forums or diaspora networks, this film was their introduction.

But Simpson’s advocacy brought legal conflict. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued pressure, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands. In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform .

Throughout his career, Simpson maintained that RSO could cure cancer and that pharmaceutical companies, governments, and medical institutions were suppressing this knowledge. He framed his work as a fight against institutional corruption. That worldview — born of desperation and distrust — is shared by many in the global cannabis movement, including communities in Rwanda who have seen institutions fail them.

Important context: Simpson’s conspiratorial framing reflects a worldview common in early cannabis advocacy. It is relevant to understanding RSO’s cultural significance, but it is not an endorsement. Our approach at OilWell is different: we fight misinformation with evidence, not with more misinformation.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was a structured oral protocol: consume 60 grams of concentrated oil over roughly 90 days. This was his cancer treatment regimen, though he applied it to many conditions. Here’s the breakdown:

Goal

Consume 60 grams (approximately 60 mL) of high-THC cannabis oil over ~90 days.

Titration Schedule

• Week 1: Half a grain of dry rice — about 10-15 mg of oil — three times daily. Total: ~30-45 mg/day.
• Weeks 2-5: Double the dose every four days. By week five, reach ~1 gram (1,000 mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram daily (roughly 333 mg per dose) until all 60 grams are consumed.

Administration Methods

• Oral (primary): Place under tongue or swallow for systemic absorption.
• Topical (secondary): Apply to skin cancers with bandages, changing every 3-4 days.
• Inhalation (not primary): Simpson acknowledged vaping for immediate symptom relief but insisted oral dosing was essential for sustained therapeutic exposure.

Tolerance and Psychoactive Effects

• Simpson claimed patients develop THC tolerance in 3-4 weeks.
• He urged nighttime dosing initially to sleep through the high.
• He warned against driving or operating machinery during titration.

Post-Protocol Maintenance

After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely for long-term health and cancer prevention.

Dietary Recommendations

Simpson advised reducing sugar, avoiding processed foods, and improving nutrition — general wellness guidance, not a systematic plan.

Critical Context for Rwandan Readers

This protocol was designed by one person based on personal experience, not clinical trials. Several points matter for anyone in Rwanda considering this approach:

• No controlled trial validation. No randomized trials, cohort studies, or documented case series support this 60-gram/90-day regimen for any cancer or condition.
• Crude, unstandardized material. Every batch differed based on starting strain, growing conditions, and extraction technique.
• Extremely high THC exposure. At peak dosing (1 gram/day of 60-90% THC oil), patients consumed 600-900 mg of delta-9 THC daily — far exceeding anything studied clinically. For context, FDA-approved dronabinol is dosed at 2.5-20 mg/day.
• Real risks at these doses. Severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder are documented risks at high THC doses [1][13][14][15].
• Oncology complexity. Cancer patients are medically complex. Using unregulated oil as a primary treatment — potentially instead of proven therapies — introduces harm beyond the oil itself.

For Rwandan cancer patients: We urge you to consult local oncology centers such as the Rwanda Cancer Centre at the Rwanda Military Hospital in Kigali, or the Butaro Cancer Centre in Burera District, before making any treatment decisions. RSO education should complement medical care, not replace it.

What Traditional RSO Was as a Product

Traditional RSO was defined by method, not lab specs. Here’s what Simpson actually made:

Source Material

High-THC, indica-dominant cannabis strains. No standardization — the starting material varied by availability and season.

Extraction Solvent

Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging leaves harmful residues.

Extraction Process

1. Place dried cannabis in a bucket.
2. Cover with solvent and agitate for minutes.
3. Filter through cheesecloth.
4. Repeat with fresh solvent.
5. Evaporate solvent in a rice cooker at high heat.
6. Transfer thick, dark oil to syringes.

Appearance

Nearly black, thick, tar-like, sticky oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile

• Fully decarboxylated (all THCa converted to delta-9 THC).
• THC-dominant (60-90% estimated), with minor cannabinoids at natural, uncontrolled ratios.
• No lab verification. No COA.

Terpene Content

Minimal to none. Solvent and high heat destroyed volatile terpenes.

Standardization and Testing

None. Every batch differed. No contaminant screening.

Residual Solvent Risk

This is a major safety concern. Traditional RSO production risks leftover toxic solvents. Modern extraction uses food-grade ethanol or CO₂ with validated testing.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many diseases. Let’s look at what the evidence actually shows.

What Simpson Was Not

He was not a scientist, physician, pharmacologist, or researcher. He never designed, conducted, or published a clinical trial. His evidence was personal testimony and informal testimonials — no controls, no verification, no blinding.

What Preclinical Literature Shows

• In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines .
• Animal models show some tumor-growth inhibition .
• These findings are scientifically interesting and justify ongoing research.

What Preclinical Literature Does NOT Show

• These findings have not translated into proven human cancer cures. The gap between lab/animal results and human clinical outcomes is vast.
• No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer.
• Small human trials in glioblastoma have been exploratory and inconclusive .

Institutional Positions

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research in labs and animals but does not endorse cannabis as a cancer treatment .
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD for seizures) and synthetic THC analogues (for chemo nausea and AIDS wasting) are approved [1].
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite — not cancer cure [1].

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create the political and cultural conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

His cancer-cure claims exceeded the evidence. Encouraging patients to rely on RSO instead of proven oncologic therapies (surgery, radiation, chemo, immunotherapy) carries genuine harm potential. Delayed or foregone treatment is a documented concern in alternative medicine.

The Legacy: How RSO Became a Generic Term

Today, “RSO” is used loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to Simpson’s original oil. In dispensaries worldwide — and potentially in any future Rwandan market — RSO can mean almost any full-spectrum extract in a syringe.

Simpson has criticized commercial products that use the RSO name while departing from his method. His model was anti-commercial: give oil away free, teach people to make it themselves. The modern industry commercialized what he distributed freely. Whether that evolution represents improvement (quality control, lab testing) or betrayal (profit extraction) depends on perspective. The cannabis community remains divided.

What is not disputed: modern RSO has evolved substantially, and those changes directly benefit you in Rwanda.

Traditional RSO vs. OilWell Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain, variable	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol (toxic)	Food-grade ethanol or CO₂, solvent-free blending
Cannabinoid profile	THC-dominant (60-90%), uncontrolled	7 defined cannabinoids at specific mg/mL
Terpene content	Destroyed by heat	Live terpenes at 5% with 7-terpene profile
Standardization	None — every batch different	Lab-tested, 553 mg/mL total cannabinoids
Lab testing	Not performed	Full panel testing (potency, pesticides, heavy metals, microbes)
Residual solvents	Significant risk	Controlled, tested, none in final product
Dosing precision	Approximate syringe-based	Measured per mL with graduated dropper
Product formats	Single thick oil only	Sublingual oil and vape cartridge
THCa preservation	No — fully decarboxylated	Yes — 1,500 mg THCa as separate ingredient
Evidence approach	Anecdotal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge: Evidence-Motivated Choices

Our formulas depart from traditional RSO deliberately, solving problems that limited Simpson’s vision:

• Multi-cannabinoid approach. Traditional RSO relied on whatever strain was available. Our formula includes 7 cannabinoids (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) because the entourage-effect literature suggests potential benefit from diversity [20][29].

• Terpene preservation. Traditional RSO had no terpenes due to heat destruction. We include live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene. Terpene bioactivity is plausible and supported preclinically, even if robust human proof remains limited [20][21][23][24][25][26][27][28].

• THCa as separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes 1,500 mg THCa, preserving the acidic precursor for non-psychoactive benefits that are lost upon heating [12].

• Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses only 90 mg delta-9 THC total, distributing the remaining 16,500 mg across other cannabinoids for a broader, more balanced profile.

• Product format innovation. Simpson envisioned one oral oil. We offer sublingual oil and vape cartridge, each with format-specific formulations respecting different pharmacokinetic profiles [14].

Solvent Safety: The Evolution That Protects You in Rwanda

Traditional RSO used naphtha or isopropyl alcohol — not food-grade. Naphtha contains benzene, toluene, and other toxins. Incomplete purging leaves harmful residues.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal with validated analytical testing (headspace gas chromatography). This is one of the clearest safety improvements over traditional RSO.

Our product is not an extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled environment. No solvents. Organic MCT oil carrier. Third-party lab testing covers potency, terpenes, pesticides, heavy metals, residual solvents, and microbes. Certificates of Analysis (COAs) are available on request — transparency you can verify from Kigali to Musanze.

The Decarboxylation Choice: You Control the Potency

Traditional RSO was always fully decarboxylated — always psychoactive. Our sublingual formula contains 1,500 mg THCa, giving you three usage options:

Option 1: Raw, No Heat (Non-Psychoactive)
All 1,500 mg stays as THCa. The THCa evidence profile suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Perfect for daytime use in Rwanda — you can work, drive, parent, function with zero impairment.

Option 2: Fully Activated (Home Decarboxylation)
Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into ~1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC — psychoactive potency comparable to traditional illegal RSO, 100% legally, because you control the activation. You can decarb only a portion in a separate container, preserving the rest raw.

Option 3: Vape, Auto-Decarboxylation
Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Onset in 1-2 minutes, duration 2-4 hours. Fastest relief available.

Conversion Chemistry: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (loss of CO₂ molecule).

This design puts potency control in your hands — aligning with Simpson’s principle that patients should control their medicine, but implementing it through chemistry rather than rhetoric.

Evidence Standards: Then and Now

Rick Simpson operated pre-legalization, pre-testing. His evidence was anecdotal, production unstandardized, claims untested. That was the environment.

This document applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews, then institutional summaries, then preclinical literature [1]-[29]. Every compound-level claim is tied to peer-reviewed sources with evidence strength clearly labeled. We honor RSO’s historical origin while committing to modern cannabinoid science.

ABOUT OILWELL CANNABIS: Our Story, Our Mission

From the Border to the Texas Medical Center

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — a stone’s throw from Reynosa, Tamaulipas, Mexico, in the Borderplex region. This is one of the most economically challenged and dangerous border zones in the Americas. McAllen has vibrant culture but limited opportunity beyond retail and healthcare. Reynosa is an industrial hub plagued by cartel violence. Colin’s childhood was marked by exposure to these realities — transporting items across the border, witnessing violence, losing best friends to death or prison. By sixteen, he had to leave home for good.

Despite the dangers, Colin didn’t fall into harder substances. He chose cannabis, learning the plant intimately in the traditional pre-legalization world, eventually transitioning from the underground to a legal, legitimate business. He became a formally trained software engineer, doing custom development for Baylor College of Medicine in the Texas Medical Center — one of the most prestigious medical institutions in the world. That combination of deep plant knowledge plus medical-grade technical precision defines OilWell’s approach.

For Rwandan readers, this origin story matters because it shows we didn’t start in a boardroom. We started in hardship, in a place where survival required grit. That same grit drives our commitment to quality and accessibility for communities like yours.

Bentley: The Dog Who Started Everything

Our company’s origin begins with a dog named Bentley. Bentley was more than a pet — he was family. When veterinarians delivered the verdict no owner wants to hear (euthanasia was the only humane option), Colin refused. Bentley was paralyzed in his back legs. Pain medications would destroy his organs. The choice was prolonged suffering or immediate mercy.

But giving up wasn’t an option. In a desperate search, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” asked a rescue worker named Jessica. That exposed a blind spot that became a mission.

Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. That hope delivered the impossible: Bentley got up, walked over, and brought his ball to play. From paralyzed to playing. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection.
• Dementia → CBC’s role in neurogenesis.
• Glaucoma → THC’s CB1 agonism for intraocular pressure reduction.
• Arthritis → Multi-pathway anti-inflammation using CBD, CBG, THCa, and beta-caryophyllene via different receptor systems.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids became critical. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Bentley’s journey was Colin’s entry into cannabis beyond getting high. It became a mission to create real solutions that alleviate pain and suffering — for pets and people. Bentley’s story is OilWell’s foundation, driving our commitment to quality, innovation, and compassionate care.

Colin’s Personal Battle: PTSD, Benzo Addiction, and Peace Gummies

Colin knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he quit cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting benzo withdrawal. It’s also available in vape form for quick relief — Colin personally uses it to manage his insomnia and severe PTSD. This is not theoretical. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills don’t.

For Rwandans dealing with trauma — whether from the genocide’s intergenerational impact, recent conflicts, or personal loss — this personal experience makes our approach credible in a way no corporate brand can be.

Doctors Use Our Formulas

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Houston: Seven Features, One Voice

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin and OilWell Cannabis in seven distinct news segments. Five different reporters sought him out across four years. No other Houston cannabis operator matches that frequency or breadth.

The features:

1. September 2019 — CBD business boom; Colin’s foundational quote about not selling snake oil.
2. March 2021 — Decriminalization efforts; Colin’s therapy quote about pain coming in many forms.
3. May 2021 — Delta-8 THC investigation; Colin’s iconic “Maybe you want to get high” honesty.
4. August 2021 — COVID vaccine giveaway; 1,000 caviar pre-rolls (~$35,000 in product) donated to encourage vaccination, coordinated with the city of Houston.
5. October 2021 — Delta-8 ban; Colin proactively removed products and warned other operators they were unknowingly shipping Schedule I narcotics.
6. October 2022 — Biden marijuana pardon; Colin revealed his personal marijuana conviction history.
7. April 2023 — Texas marijuana laws; Colin’s “Renaissance” framing of the present opportunity.

This media record is independently verified credibility — not our marketing, but ABC13’s editorial judgment. For Rwandan readers, this mainstream validation from a major U.S. network establishes a trust signal that local cannabis companies in Rwanda cannot yet claim.

Current Operations: Real Numbers, Real Location

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston — not mass-produced, but crafted with intent.

Our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone. That humility is what makes us trustworthy for Rwandan customers navigating a complex decision.

THE OILWELL RSO PHILOSOPHY: Four Pillars for Rwanda

1. Accessibility Over Gatekeeping

No medical card required. Anyone age 21+ can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. For Rwanda, this means no bureaucratic barriers. You don’t need a qualifying condition or a doctor’s permission. You need to be an adult making an informed choice.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide: use it raw for daytime anti-inflammatory benefits, or decarboxylate it into delta-9 THC for full psychoactive potency. This aligns with Simpson’s principle that patients control their medicine, but we implement it through chemistry, not rhetoric.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram, every percentage. If you can’t afford $129.99 for sublingual oil or $49.99 for vape, you can source ingredients and make your own. This echoes Simpson’s free-distribution ethos for the modern era.

The Bentley golden paste recipe we published years before RSO formulas demonstrates this pattern is foundational, not marketing. For Rwandan DIY makers, this is a gift: a proven recipe you can adapt with local ingredients (turmeric, coconut oil, black pepper) if you can access CBD isolate.

4. Evidence-Informed, Not Evidence-Overstating

Simpson operated without access to peer-reviewed literature. We have that access and use it to distinguish what’s well-supported from what’s emerging or overstated. The GENERAL KNOWLEDGE section that follows provides the research foundation for every claim we make about our products.

FARM BILL COMPLIANCE AND THE THCa LEGAL FRAMEWORK

The 2018 Farm Bill: What It Means for Rwanda

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States. This is the legal foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — 3 mg/mL — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in most U.S. states.

THCa’s legal significance: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not delta-9 THC at the point of sale, making it Farm Bill compliant. This distinction is legally significant and enables international shipping.

Customer-Controlled Activation: The Chemistry You Command

You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into ~1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC — psychoactive potency comparable to traditional illegal RSO, 100% legally, because activation happens at your discretion after purchase.

You can also decarb only a portion: transfer a controlled amount to a second container, heat it, and preserve the remainder raw. This flexibility is revolutionary for Rwandan users who need daytime functionality and nighttime relief from the same bottle.

Legal Notice for Rwandan Customers

THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with Rwandan laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility. We recommend Rwandan customers verify current import regulations with the Rwanda Revenue Authority (RRA) and Ministry of Health before ordering.

While Rwanda’s drug laws are strict, hemp-derived products with <0.3% delta-9 THC at point of sale may occupy a regulatory gray area. Our documentation clearly states the delta-9 THC content, which may assist customs clearance. However, we cannot guarantee acceptance by Rwandan authorities. Order at your own legal risk.

OPEN-SOURCE FORMULAS: Why We Publish Everything

We publish our complete RSO formulas so anyone can replicate them. The tables below are simultaneously product specifications and DIY recipes.

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Carrier: Organic MCT oil
• Active per mL: 553 mg cannabinoids
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximate doses: 40-60 per bottle (depending on serving size)
• Price: $129.99

For Rwandan DIY makers: If you can source hemp-derived distillates, you can replicate this formula. The MCT oil base is available in Kigali markets or import shops. The terpene blend requires specialized sourcing, but the cannabinoid ratios are publicly available for adaptation.

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 gram cartridge
• 510-thread: Universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Price: $49.99

The vape formula auto-decarboxylates THCa at vaping temperature (400-450°F), delivering freshly activated cannabinoids with each puff.

SOLVENT-FREE PRODUCTION: Safety You Can Verify

Our RSO is not a traditional extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled environment. No naphtha. No isopropyl alcohol. No butane.

Carrier: Organic MCT oil (medium-chain triglycerides) — a food-grade lipid that facilitates sublingual absorption and provides a neutral taste. A massive improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-Party Lab Testing: Every batch is tested for:

• Cannabinoid potency (HPLC/UHPLC, ±2% accuracy)
• Heavy metals (ICP-MS: arsenic, cadmium, lead, mercury below FDA limits)
• Pesticides (400+ compound screening via LC-MS/MS and GC-MS/MS)
• Residual solvents (headspace GC, FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

COAs available on request and via our website. For Rwandan customers, we email COAs with shipment tracking.

THE BROADER OILWELL PORTFOLIO

Beyond RSO, we produce:

• Asshole Peach — Our most popular product. Peach gummy rings with 268 mg total cannabinoids (28 mg Delta-9, 50 mg Delta-8, 20 mg Delta-10, 20 mg THCo, 100 mg CBD, 50 mg CBG). Favored by veterans for PTSD and pain relief.

• Peace Gummies — Born from Colin’s benzo withdrawal. 320 mg total cannabinoids per peach (30 mg CBN, 15 mg Delta-9, 25 mg Delta-8, 100 mg CBD, 150 mg CBG). Also available in vape form for quick relief.

• Custom Creations — Tailored formulations for specific ratios, delivery formats, or health needs (vegans, diabetics, unique dietary requirements).

TWO PRODUCT FORMATS: Which One for Your Rwanda Lifestyle?

RSO Sublingual Oil ($129.99)

For sustained, daily relief. Use raw for daytime non-psychoactive function; decarb for nighttime potency.

RSO Vape Cartridge ($49.99)

For fast breakthrough relief. Ideal for acute pain, panic, or nausea episodes. 510-thread batteries available in Kigali vape shops or online.

When to Use Each Format

Use Case	Recommended Format	Why
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	Graduated dropper (0.1 mL)
Daytime non-psychoactive	Sublingual (raw)	THCa inactive, zero impairment
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated THC + CBN

CONDITION-SPECIFIC USAGE CONTEXT

Important Disclaimer: These contexts are informed by cannabinoid research and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved, and NOT a substitute for professional care. Our products are not evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before use, especially if you have medical conditions, take medications, are pregnant/nursing, or have health concerns. Do not operate vehicles or machinery while impaired.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Breakthrough nausea: 2-3 vape puffs (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence: Delta-8 antiemetic [9], Delta-9 nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5 mL raw sublingual (anti-inflammatory, no impairment)
• Nighttime: 0.5-1.0 mL decarbed sublingual (pain relief + CBN sleep support)
• Breakthrough: Vape as needed

Evidence: CBD pain [4], Delta-9 pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: 50 mg CBN (dosage investigated in 2024 sleep literature)
• At 1.0 mL: 25 mg CBN (above threshold for reduced sleep disturbance)

Evidence: CBN sleep [16][17], cannabis and sleep reviews

Anxiety and Stress

• Daytime: 0.3 mL raw sublingual (CBD + CBG, no impairment)
• Nighttime: 1.0 mL sublingual (full profile + CBN)

Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration Principle: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by weight, metabolism, tolerance, medications.

DELIVERY AND GLOBAL ACCESSIBILITY: Getting OilWell RSO to Rwanda

Houston Same-Day Delivery

We operate the only same-day RSO delivery system in Houston, delivering free to the Texas Medical Center (world’s largest medical complex, 10M+ patient visits annually). This commitment to accessibility for patients who need it most is the same commitment we extend to Rwanda.

Nationwide and International Shipping

For Rwandan Customers:

• We ship to Rwanda via USPS Priority Mail International (6-10 business days) or FedEx/UPS International (3-5 business days, higher cost).
• All packages include full documentation: Certificates of Analysis (COAs), detailed product receipts, and customs declarations stating delta-9 THC content (<0.3%).
• Discreet packaging with no cannabis branding visible.
• Tracking provided for all orders.
• Temperature-stable packaging for hot climates (Rwanda’s average 25-28°C).
• Customs Responsibility: Rwandan customers accept all customs and legal risk. We cannot guarantee Rwandan customs will accept hemp-derived products. We recommend contacting the Rwanda Revenue Authority (RRA) and Ministry of Health before ordering.
• Pro Tip: Order the vape cartridge format for lower weight and potentially easier customs clearance. The oil bottle’s liquid volume may attract more scrutiny.

PANDEM1C SEO Technology

Our proprietary system with 14 million geopolitical locations and 300+ AI models drives organic search visibility across six continents. When someone in Kigali searches “RSO for cancer Rwanda” or “buy RSO Rwanda,” our educational content appears because we’ve invested in making real information discoverable — not because we’ve paid for ads.

HOW OILWELL FORMULAS CONNECT TO THE EVIDENCE

Every cannabinoid in our formula (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) has its own evidence profile in the GENERAL KNOWLEDGE section below. Every terpene (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries that explain what’s well-supported, what’s emerging, and what’s overstated. We don’t exempt ourselves from the same standards we apply to the broader field. That’s intentional. As Colin said in 2019: people deserve the best possible version of information to give it a fair shot and decide if it’s right for them.

This document is that research foundation.

GENERAL KNOWLEDGE: The Science Behind Every Compound

Research Method and Evidence Weighting

We prioritize sources in this order:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Mechanistic or preclinical literature (when human data are sparse)

This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and in vitro pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite/weight loss. Modest evidence for chronic pain and MS symptoms. Many claimed uses remain early-stage [1].
• FDA: Has not approved the cannabis plant for medical use. Only Epidiolex (CBD for seizures) and synthetic THC analogues (for chemo nausea and AIDS wasting) are approved [1].
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, THC-vape lung injury [1].

CANNABINOID PROFILES

CBD

• Best evidence: Purified CBD for seizure disorders (Epidiolex) [1][2].
• Anxiety: 2024 meta-analysis of 316 participants showed significant anxiolytic signal but limited clinical sample [3].
• Pain: 2024 review found promising but heterogeneous literature; trial quality limits broad analgesic claims [4].
• Sleep: 2023 review found methodology weak, few objective assessments [5].
• Safety: 2023 meta-analysis found liver enzyme elevation and possible drug-induced liver injury, especially with concentrated oral products and polypharmacy [6]. NCCIH flags diarrhea, sleepiness, appetite/mood changes, liver abnormalities, drug interactions [1].

Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications, not broad wellness claims [1]-[6].

CBG

• Evidence: Mostly review-level and preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor to major cannabinoids; interacts with CB receptors, alpha-2 adrenoceptors, 5-HT1A signaling — mechanistically interesting but not clinically established [7].
• Research areas: Possible relevance to neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily pharmacology-led hypotheses [7][8].
• Caution: Commercial CBG is sold while evidence base remains thin; claims outrun science [7].
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar PK/PD behavior; delta-8 is partial CB1 agonist, less potent than delta-9 [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, chemistry, use reports, and safety concerns; reports of adverse consequences; regulatory and product-quality issues [10].
• Manufacturing: Commercial interest tied to greater stability and easier synthesis than naturally scarce plant levels; product-byproduct and lab-testing questions matter [11].
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa

• Evidence: Important chemically/formulation-wise, low on direct human therapeutic evidence [12].
• What it is: Acidic precursor to THC; may represent large share of raw plant THC-related content. Decarboxylates to THC during heating/storage [12].
• Psychoactivity: THCa itself doesn’t produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and isn’t decarboxylated [12].
• Research: In vitro/rodent literature suggests anti-inflammatory (COX-2), immunomodulatory, neuroprotective, antineoplastic possibilities — not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor molecule whose interpretation depends on route, temperature, processing, storage [12].

Delta-9 THC

• Evidence: Strongest human evidence of psychoactive cannabinoids here, but clearest adverse-effect burden [1][13]-[15].
• Institutional support: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes — many other uses uncertain [1].
• Pain evidence: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13].
• Pharmacokinetics: Inhaled THC: onset seconds-minutes, peak 15-30 minutes, tapers over hours. Oral THC: later onset, later peak, longer duration [14].
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder; concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN

• Evidence: Weak human evidence; marketing ahead of data [12][16][17].
• Marketing vs. reality: Sleep/sedation reputation widespread, but clinical support far thinner than market suggests [16][17].
• Sleep claim review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 review concluded cannabinoid sleep research doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC degrades toward CBN under certain conditions, explaining CBN’s discussion in aging/oxidized cannabis chemistry [12].
• Bottom line: Clearest example where cultural reputation is stronger than current clinical evidence [16][17].

CBC

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacology: 2024 review argues CBC has distinct PK/PD and receptor behavior vs. better-known cannabinoids; highlights antinociceptive, antibacterial, anti-seizure as interesting targets [18].
• Older literature: Review summarizing animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance — not strong patient-facing evidence [19].
• Safety caveat: 2024 CBC review notes over-the-counter CBC products are sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

TERPENE PROFILES

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Review and preclinical, useful safety literature [20]-[22].
• Potential: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory activities — mostly from nonhuman/non-cannabis literature [21].
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens important in patch-testing [22].
• Bottom line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23].
• Research: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, possible mechanisms — explicitly states human studies lacking [23].
• Interpretation caution: Often invoked as proven sedating terpene explaining couch-lock/sleep effects — stronger claim than human evidence supports [20][23].
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood/pain/sedation remain far ahead of definitive human proof [23].

Caryophyllene

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but mostly preclinical [24].
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist — unusual, making it relevant pharmacologically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human clinical confirmation limited [24].
• Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven [24].

Pinene

• Evidence: Promising preclinical, weak human confirmation [20][25].
• Brain health: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study — emphasized well-designed clinical trials lacking [25].
• Interpretation caution: Claims that pinene reliably improves memory/attention or counterbalances THC cognitive effects remain interesting hypotheses, not settled clinical facts [20][25].
• Bottom line: Deserves scientific attention, but strong cognition-related claims are exploratory [25].

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research: Repeatedly discussed for stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation, emphasizing lack of robust human trials [25].
• Additional literature: Review discusses possible antidepressant mechanisms and neuropharmacologic relevance — remains translational rather than definitive clinical story [26].
• Safety: Oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence: Translationally interesting, early stage [20][27].
• Scoping review: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory/biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation, do not yet establish consistent human efficacy across pain, inflammation, mood [27].
• Bottom line: More interesting terpene research target, but far from clinically settled [27].

Terpinolene

• Evidence: Least clinically characterized terpene in this file [20][28].
• Systematic review: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base dominated by in silico, in vitro, animal studies — not human trials [28].
• Interpretation caution: Even recent entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, especially underdeveloped clinically [20][28].

RESEARCH LIMITS AND INTERPRETATION

• Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; others require more caution [1]-[29].
• Extract/molecule/synthetic/terpene data aren’t interchangeable. Common error: letting evidence from one category stand in for another.
• Minor cannabinoids/terpenes are commercially interesting because underexplored — but that means claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent PK all materially affect real-world interpretation [1][10][11][14].
• For THCa, chemistry is destiny: storage/heating changes exposure profile by converting acidic cannabinoids to neutral THC [12].

COMMON OVERSTATEMENTS TO AVOID

Overstatement	More Accurate
CBN is a clinically proven sleep cannabinoid.	Specific sleep evidence for CBN remains weak, with no strong validated-trial base [16][17].
Myrcene is a proven human sedative that reliably explains couch-lock.	Myrcene has plausible preclinical bioactivity, but direct human proof for this common claim is limited [20][23].
Terpenes in general have proven entourage effects in patients.	Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].
THCa is always nonpsychoactive.	THCa itself isn’t THC, but heating/processing can convert THCa to THC, changing effective exposure [12].
Delta-8 THC is safe because it’s hemp-derived.	Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing/testing concerns [9]-[11].

PRACTICAL TAKEAWAYS FOR OUR FORMULAS

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC is not trivial; it’s psychoactive with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing; not same in raw vs. heated formats.
• CBG, CBN, CBC are scientifically credible but clinically immature vs. CBD/THC.
• Listed terpenes are likely relevant to aroma/flavor and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

FINAL WORDS FOR RWANDA

OilWell Cannabis is more than a brand. It’s a promise to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends; we’re here to set them through integrity, creativity, and the mission that started when Bentley got up and brought his ball to play.

For Rwandans facing cancer, chronic pain, PTSD, or any condition where conventional medicine has fallen short: you deserve honest education, not hype. You deserve access, not gatekeeping. You deserve control over your own medicine.

We ship to Rwanda. We publish our formulas. We answer directly. And we’ll never pretend cannabis is right for everyone. But if it’s right for you, we believe OilWell RSO is the most advanced, transparent, and ethically crafted option available.

Contact us:

• Phone: +1 (832) 416-2816 (WhatsApp available for international customers)
• Email: [email protected]
• Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Order today. Your purchase includes:

• Complete product with full COA
• Decarboxylation instructions
• Open-source formula for DIY
• Access to our customer support team for dosing guidance

From Houston to Kigali, from Bentley’s miracle to your journey — we’re here to help you give cannabis a fair shot.

---